A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

NEW YORK, NY, USA I5, 2025 I Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® ...

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025 ...

Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, ...

Study finds daratumumab and tocilizumab effective in treating late antibody-mediated rejection after kidney transplant, ...

WASHINGTON — Vice President Kamala Harris has a lot of options for her next act — including possible runs for governor of California in 2026 and president in 2028 — but writing a book may be ...

However, by 4 to 6 months after starting antibiotic therapy, antibody titers declined to similar levels in both antibiotic-treated groups, regardless of their differences in arthritis symptoms.